Cytidine deaminase regulates mitochondrial biogenesis in pancreatic cancer cells
Frances, A.; Lumeau, A.; Stuani, L.; Gayral, M.; Salland, E.; Bery, N.; Pagan, D.; Hanoun, N.; Torrisani, J.; Lemarie, A.; Portais, J.-C.; Buscail, L.; Dusestti, N.; Sarry, J.-E.; Cordelier, P.
Show abstract
Despite tremendous efforts from the scientific community, pancreatic ductal adenocarcinoma (PDAC) is still a deadly disease and will soon become the second cause of death by cancer worldwide1. When surgery is not possible, therapeutic options are few and ineffective2. Patients are most often treated with Folfirinox or gemcitabine chemotherapy, that extends survival in weeks to months. Cytidine deaminase (CDA) catalyzes the irreversible hydrolytic deamination of cytidine and deoxycytidine to uridine and deoxyuridine to fuel RNA and DNA synthesis3. CDA also deaminates and neutralizes deoxycytidine-based therapies, and as such, has been identified as a major contributor of tumor chemoresistance, especially to gemcitabine in PDAC3. We previously identified that CDA is elevated in PDAC tumors at diagnosis and that CDA exerts an unexpected role on DNA replication that can be exploited for therapeutic intervention4. Very recently, CDA was associated with cellular metabolism5. Here, we show that CDA promotes mitochondrial biogenesis and oxidative phosphorylation independently of its deaminase activity. This uncloaks novel therapeutic vulnerabilities in primary cancer cells that overexpress this protein. This study shines a new light on the tumoral potential of CDA in PDAC.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Histone deacetylase inhibitor induces acetyl-CoA depletion leading to lethal metabolic stress in RAS-pathway activated cells 95%
- Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential 94%
- Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia 93%
Similar papers in this journal
- Targeting the mitochondrial RNA methyltransferase TRMT61B reveals new therapeutic opportunities in aneuploid cancer cells 93%
- Branched chain amino acid aminotransferase 2 Regulates Ferroptotic Cell Death in Cancer Cells 92%
- The Second Mitochondrial Activator of Caspases (SMAC) regulates growth, inflammation and mitochondrial integrity in cancer cells 92%
Similar papers in this journal
- Inhibiting BCKDK in triple-negative breast cancer suppress protein translation, impair mitochondrial function, and potentiate doxorubicin cytotoxicity 94%
- HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma 93%
- Aurora kinase A/AURKA interacts with the mitochondrial ATP synthase to regulate energy metabolism and cell death 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.